Alpha-1 Antitrypsin
Drug timelines are a Plus or Pro feature.
12 regulatory and trial events tracked for Alpha-1 Antitrypsin, covering 2014-07-16 to 2026-04-22. Get the full timeline:
Most recent: Clinical Trial Update: The Safety and Efficacy of Alpha-1 Antitrypsin (AAT) for the Prevention of Graft-versus-host Disease (GVHD) in Patients Receiving Hematopoietic Cell Transplant [Phase 2, Phase 3]